Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy
Raquel Tarazona, Esther Durán, Rafael Solana
Frontiers in Immunology (2016) Vol. 6
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Natural-Killer-Cell-Inspired Nanorobots with Aggregation-Induced Emission Characteristics for Near-Infrared-II Fluorescence-Guided Glioma Theranostics
Guanjun Deng, Xinghua Peng, Zhihong Sun, et al.
ACS Nano (2020) Vol. 14, Iss. 9, pp. 11452-11462
Closed Access | Times Cited: 208
Inflammation: A key process in skin tumorigenesis (Review)
Monica Neagu, Carolina Constantin, Constantin Căruntu, et al.
Oncology Letters (2018)
Open Access | Times Cited: 117
Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion
Linda Ziani, Thouraya Ben Safta-Saadoun, Johanne Gourbeix, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 19780-19794
Open Access | Times Cited: 109
Immune checkpoint inhibitors in metastatic melanoma therapy (Review)
Vedant Shah, Viraj Panchal, Abhi Shah, et al.
Medicine International (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 11
Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research
Helena Kupcová Skalníková, Jana Čížková, Jakub Červenka, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 12, pp. 2697-2697
Open Access | Times Cited: 76
Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
Hassan Sadozai, Thomas Gruber, Robert E. Hunger, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 57
Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors
Sheila López‐Cobo, Natalia Pieper, Carmen Campos‐Silva, et al.
OncoImmunology (2017) Vol. 7, Iss. 2
Open Access | Times Cited: 56
Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy
Beatriz Sánchez-Correa, Nelson López-Sejas, Esther Durán, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 5, pp. 861-870
Closed Access | Times Cited: 52
The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
Synat Kang, Xuefeng Gao, Li Zhang, et al.
Current Oncology (2021) Vol. 28, Iss. 2, pp. 1077-1093
Open Access | Times Cited: 37
Pluripotent stem cell-based immunotherapy: advances in translational research, cell differentiation, and gene modifications
Qi Lei, Hongkui Deng, Shicheng Sun
Life Medicine (2025) Vol. 4, Iss. 1
Open Access
Identification of Natural Killer Cell‐Associated Clusters in Skin Melanoma and the Impact on Prognosis and Drug Sensitivity
Jun Zhou, Renhui Cai, Danqun Zhang, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 2
Open Access
Immunosenescence: limitations of natural killer cell-based cancer immunotherapy
Raquel Tarazona, Beatriz Sánchez-Correa, Ignacio Casas-Avilés, et al.
Cancer Immunology Immunotherapy (2016) Vol. 66, Iss. 2, pp. 233-245
Closed Access | Times Cited: 43
Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care
Sima Singh, Arshid Numan, Nikhil Agrawal, et al.
International Immunopharmacology (2020) Vol. 83, pp. 106417-106417
Open Access | Times Cited: 33
Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
Eliza Turlej, Aleksandra Domaradzka, Justyna Radzka, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 403-403
Open Access
Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti‐melanoma immune response
Guillaume Sarrabayrouse, Christine Pich-Bavastro, Iotefa Teiti, et al.
International Journal of Cancer (2016) Vol. 140, Iss. 4, pp. 747-755
Open Access | Times Cited: 30
Efficacy of Juzentaihoto for Tumor Immunotherapy in B16 Melanoma Metastasis Model
Shintaro Ishikawa, Takako Ishikawa, Chiaki Tezuka, et al.
Evidence-based Complementary and Alternative Medicine (2017) Vol. 2017, pp. 1-8
Open Access | Times Cited: 30
Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA
Kiran Kundu, Susmita Ghosh, Rhitajit Sarkar, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 7, pp. 1120-1134
Open Access | Times Cited: 27
Hesperetin as an adjuvant augments protective anti‐tumour immunity responses in B16F10 melanoma by stimulating cytotoxic CD8+ T cells
Shasha Jiang, Shuang Wang, Lina Zhang, et al.
Scandinavian Journal of Immunology (2020) Vol. 91, Iss. 4
Open Access | Times Cited: 26
Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma
Satoshi Kamoto, Masahiro Shinada, Daiki Kato, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2529-2529
Open Access | Times Cited: 22
Modeling 3D Human Tumor Lymphatic Vessel Network Using High‐Throughput Platform
Somin Lee, Habin Kang, Dohyun Park, et al.
Advanced Biology (2021) Vol. 5, Iss. 2
Closed Access | Times Cited: 19
The safety of anti PD-1 therapeutics for the treatment of melanoma
Egle Ramelyte, Sabrina A. Hogan, Reinhard Dummer
Expert Opinion on Drug Safety (2016) Vol. 16, Iss. 1, pp. 41-53
Open Access | Times Cited: 20
Extracellular vesicle-mediated crosstalk between melanoma and the immune system: Impact on tumor progression and therapy response
Marco Antônio M. Pretti, Sara Santos Bernardes, Jéssica Gonçalves Vieira da Cruz, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 4, pp. 1101-1115
Closed Access | Times Cited: 20
Current Trends of Immunotherapy in the Treatment of Cutaneous Melanoma: A Review
Piyu Parth Naik
Dermatology and Therapy (2021) Vol. 11, Iss. 5, pp. 1481-1496
Open Access | Times Cited: 16
Regression in cutaneous melanoma: histological assessment, immune mechanisms and clinical implications
Karina Aivazian
Pathology (2022) Vol. 55, Iss. 2, pp. 227-235
Closed Access | Times Cited: 9
Immunobiology of Melanoma
Yee Peng Phoon, Charles S. Tannenbaum, C. Marcela Díaz‐Montero
Clinics in Plastic Surgery (2021) Vol. 48, Iss. 4, pp. 561-576
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top